What investor type does Merck & Co. fit best in FoxScore?

Merck & Co. fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.

How meaningful is the available history for Merck & Co.?

Merck & Co. currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for Merck & Co.

MRK · As of: 02/17/2026

Basic information

Type: Stock

Region: US

Sector: Health Care

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

Merck & Co. (MSD) develops and sells prescription medicines and vaccines and also operates an animal health business. Revenue comes from pharmaceutical sales to healthcare systems and from animal health products sold via veterinarians and producers. Customers are global, with major markets in the US and Europe.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Merck & Co. (MRK) currently has a total score of 63 points, placing it in the strong range. The score is made up of Performance (54), Stability (61) and Trend (90). The profile is clearly uneven: Trend stands out while Performance is more neutral.

Performance scores 54 points (neutral). Key strength: 1Y return at 44.1 %. Weaker metric: 3Y return at 14.0 %.

Stability scores 61 points (strong). Key strength: Sharpe ratio (90d) at 2.51. Main drag: max drawdown (1Y) at -44.7 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 90 points (very strong). Key strength: trend strength at 0.96. Even the weakest metric remains solid in absolute terms: 12M momentum at 31.4 %.

Overall, the profile has a clear strength in Trend, while Performance is the main limiter. On a metric level, Sharpe ratio (90d) stands out, while max drawdown (1Y) is the main weak spot.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

strong

Scores

Metrics

FAQ

What investor type does Merck & Co. fit best in FoxScore?: Merck & Co. fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for Merck & Co.?: Merck & Co. currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.